US Patent Issued to IWATE MEDICAL UNIVERSITY on June 2 for "Humanized anti-GPC-1 antibody" (Japanese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,955, issued on June 2, was assigned to IWATE MEDICAL UNIVERSITY (Iwate, Japan).

"Humanized anti-GPC-1 antibody" was invented by Tetsuji Naka (Shiwa-gun, Japan) and Satoshi Serada (Shiwa-gun, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a humanized antibody that specifically binds to Glypican-1 (GPC-1), and also provides technologies, methods, medicines, and the like related to the humanized antibody. In one aspect, the present disclosure provides a humanized anti-GPC-1 monoclonal antibody that has a high affinity for GPC-1 and has high internalization activity in GPC-1-positive cells. In another aspect, the pre...